Recent Updates
Recently added Catalysts
WST Positive Sentiment Score: 70/100

West to Participate in Upcoming Investor Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...

Key Takeaway: West Pharmaceutical Services, Inc. announced its participation in the William Blair 44th Annual Growth Stock Conference on June 4, 2024. The event will be available for live audio webcast through the company's website, with a replay option for 90 days post-event. West, a leader in innovative injectable drug solutions, reported $2.95 billion in net sales for fiscal year 2023, highlighting its strong market position in supporting drug developers.

Market Sentiment Analysis

POSITIVE FACTORS

  • West Pharmaceutical Services is recognized as a global leader in injectable drug administration.
  • The company presented at a reputable investor conference, indicating strong industry interest and engagement.
  • West reported impressive net sales of $2.95 billion in the fiscal year 2023.

Full Press Release Details

EXTON, Pa. , May 28, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the William Blair 44 th Annual Growth Stock Conference in Chicago, IL on Tuesday, June 4, 2024 at 8:00 AM CT .
A live audio webcast of the event will be available in the "Investors" section of the Company's website at www.westpharma.com . Replay of the webcasts will be available for approximately 90 days after the event.
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.
Headquartered in Exton, Pennsylvania , West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST ) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com .
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
SOURCE West Pharmaceutical Services, Inc.

21 %

Frequently Asked Questions

When will West Pharmaceutical Services present at the conference?

West Pharmaceutical Services will present on June 4, 2024, at 8:00 AM CT.

How can I access the live audio webcast?

The live audio webcast will be available in the 'Investors' section on their website.

What is West Pharmaceutical Services known for?

West is known for high-quality innovative solutions for injectable drug administration.

What were West's net sales in fiscal year 2023?

In fiscal year 2023, West recorded net sales of $2.95 billion.

How many components does West deliver annually?

West delivers approximately 43 billion components and devices each year.

Last updated: May 28, 2024